197 related articles for article (PubMed ID: 15580028)
41. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
42. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ
Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643
[TBL] [Abstract][Full Text] [Related]
43. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
[TBL] [Abstract][Full Text] [Related]
44. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
46. Extract of Aneilema keisak inhibits transforming growth factor-β-dependent signalling by inducing Smad2 downregulation in keloid fibroblasts.
Kim WS; Lee JS; Bae GY; Kim JJ; Chin YW; Bahk YY; Min HG; Cha HJ
Exp Dermatol; 2013 Jan; 22(1):69-71. PubMed ID: 23278899
[TBL] [Abstract][Full Text] [Related]
47. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
48. Keloid pathogenesis via Drosophila similar to mothers against decapentaplegic (SMAD) signaling in a primary epithelial-mesenchymal in vitro model treated with biomedical-grade chitosan porous skin regenerating template.
Lim CK; Halim AS; Yaacob NS; Zainol I; Noorsal K
J Biosci Bioeng; 2013 Apr; 115(4):453-8. PubMed ID: 23177217
[TBL] [Abstract][Full Text] [Related]
49. Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
Jiang Z; Yu Q; Xia L; Zhang Y; Wang X; Wu X; Gao Z
Cell Physiol Biochem; 2016; 40(1-2):207-218. PubMed ID: 27855376
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of RACK1 inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Zhou P; Shi L; Li Q; Lu D
Int J Clin Exp Med; 2015; 8(9):15262-8. PubMed ID: 26629012
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
52. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
[TBL] [Abstract][Full Text] [Related]
53. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
54. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
McGaha TL; Phelps RG; Spiera H; Bona C
J Invest Dermatol; 2002 Mar; 118(3):461-70. PubMed ID: 11874485
[TBL] [Abstract][Full Text] [Related]
55. [Recombinant human bone morphogenetic protein 7 inhibits the proliferation and extracellular matrix secretion of fibroblast of urethral scars].
Wu Y; Ma LM; Cai B; Li HL; Xing QW
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):438-442. PubMed ID: 28219131
[No Abstract] [Full Text] [Related]
56. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts.
Gauglitz GG; Bureik D; Zwicker S; Ruzicka T; Wolf R
Skin Pharmacol Physiol; 2015; 28(3):115-23. PubMed ID: 25502330
[TBL] [Abstract][Full Text] [Related]
57. Asiaticoside hinders the invasive growth of keloid fibroblasts through inhibition of the GDF-9/MAPK/Smad pathway.
Wu X; Bian D; Dou Y; Gong Z; Tan Q; Xia Y; Dai Y
J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28346732
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
59. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
60. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.
Li J; Li Z; Wang S; Bi J; Huo R
Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
